Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

1.1K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

27
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
27

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Machine Learning for Early Prediction of Metastasis in a Swedish Multicancer Cohort.

JCO clinical cancer informatics·2026
Same author

Artificial intelligence-enabled electrocardiography to predict impending episodes of ventricular tachycardia in individuals under continuous heart rhythm monitoring.

The Cochrane database of systematic reviews·2026
Same author

M-ClustEHR: A multimodal clustering approach for electronic health records.

Artificial intelligence in medicine·2024
Same author

Surveillance of communicable diseases using social media: A systematic review.

PloS one·2023
Same author

Style-transfer counterfactual explanations: An application to mortality prevention of ICU patients.

Artificial intelligence in medicine·2023
Same author

Explainable AI for Data-Driven Feedback and Intelligent Action Recommendations to Support Students Self-Regulation.

Frontiers in artificial intelligence·2021

Related Experiment Video

Updated: Oct 13, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Exploiting complex medical data with interpretable deep learning for adverse drug event prediction.

Jonathan Rebane1, Isak Samsten1, Panagiotis Papapetrou1

  • 1Department of Computer and Systems Sciences, Stockholm University, Stockholm, Sweden.

Artificial Intelligence in Medicine
|November 10, 2021
PubMed
Summary

Deep learning models predict adverse drug events (ADEs) using electronic patient records. Augmenting interpretable models with clinical text and risk features improved prediction accuracy and interpretability.

Keywords:
Adverse drug eventsDeep learningExplainable AIMedical recordsText mining

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

718
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Related Experiment Videos

Last Updated: Oct 13, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

718
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Area of Science:

  • Medical informatics
  • Computational biology
  • Artificial intelligence in healthcare

Background:

  • Deep learning models are increasingly used for predictive modeling and knowledge extraction from medical records.
  • Temporal attention mechanisms and decay factors are crucial for incorporating time-sensitive information and enhancing interpretability in medical event prediction.

Purpose of the Study:

  • To empirically evaluate state-of-the-art medical-code based models for adverse drug event (ADE) prediction.
  • To augment an interpretable deep learning architecture with numerical risk and clinical text features for improved ADE prediction.
  • To assess the utility of attention mechanisms for medical code-level and text-level interpretability in understanding ADEs.

Main Methods:

  • Utilized a large Electronic Patient Record (EPR) dataset including diagnoses, medications, and clinical text.
  • Employed and evaluated two state-of-the-art medical-code based deep learning models for ADE prediction.
  • Augmented an interpretable deep learning architecture with numerical risk and clinical text features.

Main Results:

  • Empirical evaluation of two baseline models on diagnosis and medication data for ADE prediction.
  • Demonstrated improved predictive performance of the augmented interpretable deep learning architecture compared to baselines.
  • Assessed the importance of attention mechanisms for medical code and text interpretability in ADE prediction.

Conclusions:

  • Augmenting interpretable deep learning models with clinical text and numerical risk features enhances ADE prediction accuracy.
  • Attention mechanisms are valuable for achieving medical code-level and text-level interpretability, offering insights into ADE occurrence.
  • The study provides a framework for leveraging diverse data types within EPRs for robust ADE prediction and understanding.